XBiotech Inc.
XBIT
$2.69
-$0.26-8.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.39% | -20.14% | -0.50% | 12.35% | -30.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.87% | -7.23% | 12.88% | 51.90% | 1.48% |
| Operating Income | -1.87% | 7.23% | -12.88% | -51.90% | -5.21% |
| Income Before Tax | -122.83% | 29.05% | -50.28% | -158.94% | -80.34% |
| Income Tax Expenses | 58.59% | -97.08% | -135.21% | 167.57% | -117.13% |
| Earnings from Continuing Operations | -126.71% | 31.90% | -48.78% | -162.11% | -44.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -126.71% | 31.90% | -48.78% | -162.11% | -44.71% |
| EBIT | -1.87% | 7.23% | -12.88% | -51.90% | -5.21% |
| EBITDA | -1.91% | 7.70% | -13.32% | -55.49% | -5.62% |
| EPS Basic | -126.46% | 31.96% | -48.68% | -161.96% | -44.77% |
| Normalized Basic EPS | -122.63% | 29.12% | -50.22% | -158.91% | -80.33% |
| EPS Diluted | -121.80% | 31.96% | -48.28% | -161.96% | -47.81% |
| Normalized Diluted EPS | -122.63% | 29.12% | -50.22% | -158.91% | -80.33% |
| Average Basic Shares Outstanding | 0.08% | 0.12% | 0.06% | 0.02% | 0.01% |
| Average Diluted Shares Outstanding | 0.08% | 0.12% | 0.06% | 0.02% | 0.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
